The University of Southampton
University of Southampton Institutional Repository

Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption

Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
Coffee, a major dietary source of caffeine, is among the most widely consumed beverages in the world and has received considerable attention regarding health risks and benefits. We conducted a genome-wide (GW) meta-analysis of predominately regular-type coffee consumption (cups per day) among up to 91 462 coffee consumers of European ancestry with top single-nucleotide polymorphisms (SNPs) followed-up in ~30 062 and 7964 coffee consumers of European and African-American ancestry, respectively. Studies from both stages were combined in a trans-ethnic meta-analysis. Confirmed loci were examined for putative functional and biological relevance. Eight loci, including six novel loci, met GW significance (log10Bayes factor (BF)>5.64) with per-allele effect sizes of 0.03–0.14 cups per day. Six are located in or near genes potentially involved in pharmacokinetics (ABCG2, AHR, POR and CYP1A2) and pharmacodynamics (BDNF and SLC6A4) of caffeine. Two map to GCKR and MLXIPL genes related to metabolic traits but lacking known roles in coffee consumption. Enhancer and promoter histone marks populate the regions of many confirmed loci and several potential regulatory SNPs are highly correlated with the lead SNP of each. SNP alleles near GCKR, MLXIPL, BDNF and CYP1A2 that were associated with higher coffee consumption have previously been associated with smoking initiation, higher adiposity and fasting insulin and glucose but lower blood pressure and favorable lipid, inflammatory and liver enzyme profiles (P<5 × 10−8).Our genetic findings among European and African-American adults reinforce the role of caffeine in mediating habitual coffee consumption and may point to molecular mechanisms underlying inter-individual variability in pharmacological and health effects of coffee.
1359-4184
647-656
Cornelis, M.C.
20a34bde-18e1-4be4-a2c8-6dbbf8d0a5a1
Byrne, E.M.
58ca1c57-e14c-4d53-81ea-fac74a04af10
Esko, T.
75bb54d0-55cb-45d7-8870-598880bd2b09
Nalls, M.A.
f952a2fe-c78a-492d-8df0-4277a6ab06e9
Ganna, A
d59d3152-e0d7-4090-9da2-6ca7816c4857
Paynter, N
d5f35f9c-43d3-4547-ae94-11ae181c32a7
Monda, K L
b084e6a2-2dd4-430e-836e-5b9ede034af2
Amin, N
0ed94dbd-2fb8-4d44-be2f-a60adaaacb1a
Fischer, K
f8511ba8-c64b-4b72-ab73-86650a819ecd
Renstrom, F
0944963d-fe4a-4cbf-92ae-2edc783793bb
Ngwa, J S
f82577fe-cc5c-44f7-8586-b89a295d92b3
Huikari, V
653d1022-af62-440b-9015-5ab6582e47c8
Cavadino, A
49044e19-31f5-476c-b156-646d0398458f
Nolte, I M
77cb71fe-c935-4b49-a5be-958ede59a293
Teumer, A
318741af-604f-45db-ae0f-4394e7bc9f30
Yu, K
d3b7ff84-88e5-4fea-a9ad-464824bab626
Marques-Vidal, P
79779608-fa9c-40dc-9f7d-69f89edbe1a5
Rawal, R
f7b45fde-82b2-4920-9669-0c883d0365e2
Manichaikul, A
bf46a359-6db6-4253-891f-9bb67390ee26
Wojczynski, M K
7962c358-02f0-43ad-b256-d018d3d6c6aa
Vink, J M
8d15f3a0-fe08-49d8-9b8f-44d30403b5c5
Zhao, J H
c0f7c79a-e100-4d92-9de4-9d872584f316
Burlutsky, G
fb192880-ce6c-449b-92a4-4abd24d7425f
Lahti, J
5c49c42d-aa4b-4cba-b8b0-f571b8c28a78
Mikkilä, V
ceb03d29-00c2-4fbb-b377-8a8d1027883d
Lemaitre, R N
259ec55d-e542-46eb-bd75-87e80eafdd33
Eriksson, J
70be0221-e251-4509-96df-b8bed04dce49
Musani, S K
5af755ee-ab88-4f7f-906c-788543f339f7
Tanaka, T
13fcab0c-a5cd-41af-9164-065d839dec5f
Geller, F
baa6e093-13d0-4240-af53-feba023c77f2
Luan, J
d44a27d1-e052-44ce-b94f-3abe519d1804
Hui, J
956cc018-f64b-40da-83c1-e0590c06a25b
Mägi, R
85ec1bb9-7fac-4568-b5da-7be54415b3b6
Dimitriou, M
57352d3a-9d07-4ea2-a3bd-58edb8b0b612
Garcia, M E
23a457ae-ce04-4f35-a625-21b06680b505
Ho, W-K
075e5f98-67c2-4e05-bfb3-aed957e3e20e
Wright, M J
f56462d8-9fee-4335-862d-9cce887b0d9c
Rose, L M
c987efde-65e3-4cc2-a601-6039f0931932
Magnusson, P K E
cb69e516-695c-4bb3-989f-3007ae757462
Pedersen, N L
aec2666a-f3cb-41c4-8375-b62f304abbf5
Couper, D
8e45bb0e-635b-44c3-b638-83f2e640e44e
Oostra, B A
2ae09c37-7adc-499f-80a7-5ee3ef3e78ce
Hofman, A
ece9dbea-8c2b-4f2f-81eb-7aa28075cf7a
Ikram, M A
d2cc08b6-4030-4136-aaf7-c2f4abb75772
Tiemeier, H W
238eb25d-e1e5-4459-a9a7-d82cefa34ff8
Uitterlinden, A G
a1cba0b3-0fea-487b-8d8c-dcafc1655f67
van Rooij, F J A
8de97f93-3f9d-473d-99e1-1442040690a1
Barroso, I
77e9d9be-1982-4d2e-9488-1a77fb512a8f
Johansson, I
205e4144-fd49-4dda-9a23-c529e73d888a
Morrison, Karen
f00890f0-2fde-4dbd-a73b-7422e1b0ede8
The Coffee and Caffeine Genetics Consortium
International Parkinson's Disease Genomics Consortium (IPDGC)
North American Brain Expression Consortium (NABEC)
UK Brain Expression Consortium (UKBEC)
Cornelis, M.C.
20a34bde-18e1-4be4-a2c8-6dbbf8d0a5a1
Byrne, E.M.
58ca1c57-e14c-4d53-81ea-fac74a04af10
Esko, T.
75bb54d0-55cb-45d7-8870-598880bd2b09
Nalls, M.A.
f952a2fe-c78a-492d-8df0-4277a6ab06e9
Ganna, A
d59d3152-e0d7-4090-9da2-6ca7816c4857
Paynter, N
d5f35f9c-43d3-4547-ae94-11ae181c32a7
Monda, K L
b084e6a2-2dd4-430e-836e-5b9ede034af2
Amin, N
0ed94dbd-2fb8-4d44-be2f-a60adaaacb1a
Fischer, K
f8511ba8-c64b-4b72-ab73-86650a819ecd
Renstrom, F
0944963d-fe4a-4cbf-92ae-2edc783793bb
Ngwa, J S
f82577fe-cc5c-44f7-8586-b89a295d92b3
Huikari, V
653d1022-af62-440b-9015-5ab6582e47c8
Cavadino, A
49044e19-31f5-476c-b156-646d0398458f
Nolte, I M
77cb71fe-c935-4b49-a5be-958ede59a293
Teumer, A
318741af-604f-45db-ae0f-4394e7bc9f30
Yu, K
d3b7ff84-88e5-4fea-a9ad-464824bab626
Marques-Vidal, P
79779608-fa9c-40dc-9f7d-69f89edbe1a5
Rawal, R
f7b45fde-82b2-4920-9669-0c883d0365e2
Manichaikul, A
bf46a359-6db6-4253-891f-9bb67390ee26
Wojczynski, M K
7962c358-02f0-43ad-b256-d018d3d6c6aa
Vink, J M
8d15f3a0-fe08-49d8-9b8f-44d30403b5c5
Zhao, J H
c0f7c79a-e100-4d92-9de4-9d872584f316
Burlutsky, G
fb192880-ce6c-449b-92a4-4abd24d7425f
Lahti, J
5c49c42d-aa4b-4cba-b8b0-f571b8c28a78
Mikkilä, V
ceb03d29-00c2-4fbb-b377-8a8d1027883d
Lemaitre, R N
259ec55d-e542-46eb-bd75-87e80eafdd33
Eriksson, J
70be0221-e251-4509-96df-b8bed04dce49
Musani, S K
5af755ee-ab88-4f7f-906c-788543f339f7
Tanaka, T
13fcab0c-a5cd-41af-9164-065d839dec5f
Geller, F
baa6e093-13d0-4240-af53-feba023c77f2
Luan, J
d44a27d1-e052-44ce-b94f-3abe519d1804
Hui, J
956cc018-f64b-40da-83c1-e0590c06a25b
Mägi, R
85ec1bb9-7fac-4568-b5da-7be54415b3b6
Dimitriou, M
57352d3a-9d07-4ea2-a3bd-58edb8b0b612
Garcia, M E
23a457ae-ce04-4f35-a625-21b06680b505
Ho, W-K
075e5f98-67c2-4e05-bfb3-aed957e3e20e
Wright, M J
f56462d8-9fee-4335-862d-9cce887b0d9c
Rose, L M
c987efde-65e3-4cc2-a601-6039f0931932
Magnusson, P K E
cb69e516-695c-4bb3-989f-3007ae757462
Pedersen, N L
aec2666a-f3cb-41c4-8375-b62f304abbf5
Couper, D
8e45bb0e-635b-44c3-b638-83f2e640e44e
Oostra, B A
2ae09c37-7adc-499f-80a7-5ee3ef3e78ce
Hofman, A
ece9dbea-8c2b-4f2f-81eb-7aa28075cf7a
Ikram, M A
d2cc08b6-4030-4136-aaf7-c2f4abb75772
Tiemeier, H W
238eb25d-e1e5-4459-a9a7-d82cefa34ff8
Uitterlinden, A G
a1cba0b3-0fea-487b-8d8c-dcafc1655f67
van Rooij, F J A
8de97f93-3f9d-473d-99e1-1442040690a1
Barroso, I
77e9d9be-1982-4d2e-9488-1a77fb512a8f
Johansson, I
205e4144-fd49-4dda-9a23-c529e73d888a
Morrison, Karen
f00890f0-2fde-4dbd-a73b-7422e1b0ede8

Cornelis, M.C., Byrne, E.M. and Esko, T. , The Coffee and Caffeine Genetics Consortium, International Parkinson's Disease Genomics Consortium (IPDGC) and North American Brain Expression Consortium (NABEC) et al. (2015) Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Molecular Psychiatry, 20 (5), 647-656. (doi:10.1038/mp.2014.107). (PMID:25288136)

Record type: Article

Abstract

Coffee, a major dietary source of caffeine, is among the most widely consumed beverages in the world and has received considerable attention regarding health risks and benefits. We conducted a genome-wide (GW) meta-analysis of predominately regular-type coffee consumption (cups per day) among up to 91 462 coffee consumers of European ancestry with top single-nucleotide polymorphisms (SNPs) followed-up in ~30 062 and 7964 coffee consumers of European and African-American ancestry, respectively. Studies from both stages were combined in a trans-ethnic meta-analysis. Confirmed loci were examined for putative functional and biological relevance. Eight loci, including six novel loci, met GW significance (log10Bayes factor (BF)>5.64) with per-allele effect sizes of 0.03–0.14 cups per day. Six are located in or near genes potentially involved in pharmacokinetics (ABCG2, AHR, POR and CYP1A2) and pharmacodynamics (BDNF and SLC6A4) of caffeine. Two map to GCKR and MLXIPL genes related to metabolic traits but lacking known roles in coffee consumption. Enhancer and promoter histone marks populate the regions of many confirmed loci and several potential regulatory SNPs are highly correlated with the lead SNP of each. SNP alleles near GCKR, MLXIPL, BDNF and CYP1A2 that were associated with higher coffee consumption have previously been associated with smoking initiation, higher adiposity and fasting insulin and glucose but lower blood pressure and favorable lipid, inflammatory and liver enzyme profiles (P<5 × 10−8).Our genetic findings among European and African-American adults reinforce the role of caffeine in mediating habitual coffee consumption and may point to molecular mechanisms underlying inter-individual variability in pharmacological and health effects of coffee.

This record has no associated files available for download.

More information

e-pub ahead of print date: 7 October 2014
Published date: May 2015
Organisations: Medical Education

Identifiers

Local EPrints ID: 398187
URI: http://eprints.soton.ac.uk/id/eprint/398187
ISSN: 1359-4184
PURE UUID: 69419f1f-6528-4d94-92ee-dc251d829b30
ORCID for Karen Morrison: ORCID iD orcid.org/0000-0003-0216-5717

Catalogue record

Date deposited: 20 Jul 2016 14:07
Last modified: 15 Mar 2024 01:31

Export record

Altmetrics

Contributors

Author: M.C. Cornelis
Author: E.M. Byrne
Author: T. Esko
Author: M.A. Nalls
Author: A Ganna
Author: N Paynter
Author: K L Monda
Author: N Amin
Author: K Fischer
Author: F Renstrom
Author: J S Ngwa
Author: V Huikari
Author: A Cavadino
Author: I M Nolte
Author: A Teumer
Author: K Yu
Author: P Marques-Vidal
Author: R Rawal
Author: A Manichaikul
Author: M K Wojczynski
Author: J M Vink
Author: J H Zhao
Author: G Burlutsky
Author: J Lahti
Author: V Mikkilä
Author: R N Lemaitre
Author: J Eriksson
Author: S K Musani
Author: T Tanaka
Author: F Geller
Author: J Luan
Author: J Hui
Author: R Mägi
Author: M Dimitriou
Author: M E Garcia
Author: W-K Ho
Author: M J Wright
Author: L M Rose
Author: P K E Magnusson
Author: N L Pedersen
Author: D Couper
Author: B A Oostra
Author: A Hofman
Author: M A Ikram
Author: H W Tiemeier
Author: A G Uitterlinden
Author: F J A van Rooij
Author: I Barroso
Author: I Johansson
Author: Karen Morrison ORCID iD
Corporate Author: The Coffee and Caffeine Genetics Consortium
Corporate Author: International Parkinson's Disease Genomics Consortium (IPDGC)
Corporate Author: North American Brain Expression Consortium (NABEC)
Corporate Author: UK Brain Expression Consortium (UKBEC)

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×